May 8, 2018 Clinical Research/Diagn. PR/Corporate Product Launch

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 08 May 2018 Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting New and updated pivotal combination data from the Tecentriq lung programme, including overall survival (OS) results from IMpower150 and progression free survival (PFS) results from IMpower131 New, longer follow-up data... Read more

May 4, 2018 PR/Corporate

AMETEK To Present At Oppenheimer's 13th Annual Industrial Growth Conference

BERWYN, Pa., May 4, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) will present at Oppenheimer’s 13th Annual Industrial Growth Conference on Wednesday, May 9, 2018. David Zapico, Chairman and Chief Executive Officer, will represent the Company. AMETEK’s presentation is scheduled for 8:15 AM ET. The presentation will be simultaneously webcast over the Internet. The live... Read more

May 3, 2018 PR/Corporate

Honeywell Names Bin Shen President of Honeywell China

May 03, 2018 Shanghai, China, May 3, 2018 – Honeywell (NYSE: HON) today announced that Bin Shen was appointed as President of Honeywell China, effective May 7, 2018. Bin will directly report to Shane Tedjarati, President of Honeywell Global High Growth Regions.   “Over the past decade, we have witnessed rapid development in China. Honeywell China... Read more

May 3, 2018 Liq. Handling & Robotics PR/Corporate

QIAGEN reports results for first quarter 2018

Net sales of $343.6 million (+12% actual, +6% CER) vs. 5% CER guidance EPS $0.14; adjusted EPS $0.26 ($0.25 CER) vs. ~$0.23-0.24 CER guidance Sample to Insight portfolio building momentum: QIAstat-Dx, a next-generation platform offering syndromic insights for a broad range of applications, launched in Europe QuantiFERON latent TB test growth fueled by geographic expansion... Read more

May 2, 2018 Lab Top-10 Life Science Tools PR/Corporate

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Bank of America Merrill Lynch Health Care Conference in Las Vegas, NVWednesday, May 16, 2018 at 3:40 pm Pacific Time The live webcast can be accessed in the Investor Relations... Read more

April 30, 2018 Licensing, IP, and Legal PR/Corporate

Xylem Inc. to Participate in the Oppenheimer 13th Annual Industrial Growth Conference

RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 30, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President, Continuous Improvement & Business Transformation Tony Milando and Sr. Director of Investor Relations Matt Latino will participate in group discussions at the Oppenheimer 13th... Read more

April 30, 2018 Lab Top-10 PR/Corporate

Thermo Fisher Scientific to Host Analyst Meeting

WALTHAM, Mass., April 30, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2018 Analyst Meeting on Wednesday, May 23, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City. The meeting... Read more

April 30, 2018 Liq. Handling & Robotics M&A, Partnerships PR/Corporate Product Launch

QIAGEN reports results for fourth quarter and full-year 2017, announces STAT-Dx acquisition and new $200 million share repurchase

Solid Q4 results as QIAGEN achieves full-year 2017 targets: Q4 2017: Net sales $396.9 million ( 8% actual, 5% CER); adjusted net sales rise 6% CER excluding portfolio changes vs. 5-6% CER guidance Q4 2017: EPS -$0.18 including impact of predominantly non-cash U.S. tax reform charge; adjusted EPS $0.43 ($0.43 CER) vs. ~$0.41-42 CER guidance... Read more